11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD-1) inhibitors (Poxel)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD-1) inhibitors (Poxel)
Drug Alias Name11beta-hydroxysteroid dehydrogenase-1 inhibitors (Merck Serono)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWestern EuropeFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaPoxel Sa
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A